Altman Self-Rating Mania Scale (ASRM)

Abstract

The Altman Self-Rating Mania Scale (ASRM) is a concise, 5-item self-report psychometric instrument developed by Edward G. Altman, Donald Hedeker, Jan L. Peterson, and John M. Davis in 1997. It was designed to assess the presence and severity of manic and hypomanic symptoms in clinical and research populations. Designed to align directly with the diagnostic criteria for a manic episode outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV and DSM-5), the instrument evaluates five cardinal symptom domains of bipolar spectrum pathology: elevated or euphoric mood, inflated self-esteem or grandiosity, decreased need for sleep, pressured speech, and psychomotor agitation or heightened motor/social activity. Each item is measured using a 5-point Likert-type anchor system ranging from 0 (absence of symptom or normal baseline) to 4 (severe or maximal manifestation of manic behavior), yielding a cumulative composite score ranging from 0 to 20.

Extensive psychometric investigations have established the ASRM as a reliable and valid instrument with exceptional diagnostic utility. Receiver operating characteristic (ROC) analyses consistently demonstrate that a cutoff score of 6 or higher optimally differentiates manic or hypomanic states from euthymic or depressed states, yielding sensitivity and specificity coefficients typically exceeding 0.85. The scale exhibits robust internal consistency, with initial validation studies reporting a Cronbach’s alpha of 0.79 in acute clinical mania samples, and subsequent research demonstrating coefficients between 0.75 and 0.86 across diverse international cohorts. Concurrent and convergent validity are documented through high correlations with established clinician-rated instruments, including the Young Mania Rating Scale (YMRS) and the Clinician-Administered Rating Scale for Mania (CARS-M), while discriminant validity is confirmed through negligible or negative correlations with depressive measures such as the Hamilton Depression Rating Scale (HAM-D). Due to its brevity, ease of administration, and conceptual alignment with neurobiological and behavioral manifestations of mania, the ASRM serves as an essential tool for longitudinal monitoring, clinical trials, and outpatient triage in affective disorders.

Keywords

Altman Self-Rating Mania Scale, ASRM, bipolar disorder, mania, hypomania, psychometrics, self-report scale, psychiatric rating scale, Young Mania Rating Scale, mood disorders, internal consistency, affective neuroscience

Authors

The Altman Self-Rating Mania Scale was conceptualized, developed, and psychometrically validated by a collaborative research team affiliated with the Department of Psychiatry at the University of Illinois at Chicago and the Michael Reese Hospital and Medical Center:

• Edward G. Altman, M.D. — Associate Professor of Psychiatry, Department of Psychiatry, College of Medicine, University of Illinois at Chicago; Director of Clinical Research at Michael Reese Hospital. Dr. Altman has authored seminal research on affective disorders, geriatric psychopathology, and the development of clinical assessment metrics for bipolar disorder.
• Donald Hedeker, Ph.D. — Professor of Biostatistics, Department of Public Health Sciences, University of Chicago (formerly at the University of Illinois at Chicago). Dr. Hedeker is an internationally recognized expert in statistical methods for psychiatric research, longitudinal mixed-effects modeling, and psychometric methodology.
• Jan L. Peterson, M.S.W., LCSW — Clinical Research Specialist and psychiatric social worker, Michael Reese Hospital and the University of Illinois at Chicago, specializing in affective disorder clinical trials and patient-reported outcome measures.
• John M. Davis, M.D. — Gilman Professor of Psychiatry and Research Professor of Medicine, Department of Psychiatry, University of Illinois at Chicago. Dr. Davis is a renowned psychopharmacologist widely recognized for his foundational work on the biochemical basis of mood disorders, meta-analyses of antipsychotic and mood-stabilizing agents, and clinical trial design.

Purpose

The primary clinical and psychometric objective of the Altman Self-Rating Mania Scale is to provide a brief, reliable, and standardized self-report metric capable of screening for, dimensionalizing, and tracking the longitudinal severity of manic and hypomanic episodes. Traditionally, the quantification of mania has relied almost exclusively on clinician-administered instruments, such as the Young Mania Rating Scale (YMRS; Young et al., 1978) or the Bech-Rafaelsen Mania Scale (BRMS; Bech et al., 1979). While clinician-rated scales remain standard in controlled psychopharmacological clinical trials, they possess distinct operational limitations: they require comprehensive psychiatric training to achieve acceptable inter-rater reliability, necessitate prolonged face-to-face interviewing sessions lasting between 15 and 45 minutes, and cannot be readily completed by patients remotely between clinical visits.

A longstanding skepticism existed within clinical psychiatry regarding the feasibility and clinical validity of self-report measures in manic populations. Historical assumptions posited that manic patients exhibit poor illness awareness (anosognosia), impaired executive insight, and cognitive disinhibition that would prevent accurate self-reflection. However, Altman and colleagues demonstrated that individuals experiencing acute mania or hypomania can reliably quantify their subjective experience of heightened energy, cognitive acceleration, reduced sleep requirements, and affective shifts when the operational descriptions are framed clearly, concretely, and behavioral terms. The ASRM was engineered specifically to bridge this gap, offering a self-administered instrument requiring less than five minutes to complete, yet maintaining strong diagnostic fidelity and psychometric alignment with gold-standard clinician interviews.

In routine clinical practice, the ASRM serves multiple complementary roles. As a screening instrument, it aids in identifying undetected hypomanic or manic switches in patients treated for major depressive disorder, mitigating the risk of antidepressant-induced destabilization. In longitudinal mood charting and collaborative care models, it allows outpatients to monitor fluctuations in their affective state, detecting subthreshold hypomanic symptoms before they escalate into fully syndromic manic episodes requiring hospitalization. In psychiatric research and clinical trials, the ASRM functions as a patient-centered secondary outcome metric, measuring treatment response, evaluating functional recovery, and testing novel pharmaceutical and psychotherapeutic interventions designed to stabilize mood instability in bipolar disorder.

Psychological Construct

The psychological construct evaluated by the ASRM is acute manic/hypomanic syndromal severity as defined within contemporary psychiatric taxonomy (DSM-IV and DSM-5). Mania is characterized not merely by subjective happiness, but by an expansive neurobehavioral dysregulation marked by sustained neurochemical and psychomotor activation. The scale focuses on five core dimensional expressions of this construct:

1. Positive Mood (Affective Elevation and Expansiveness)

Manic affect is distinguished from normal euthymia through its persistence, intensity, and disproportionality to environmental circumstances. This dimension evaluates the spectrum extending from normative euthymic contentment to persistent euphoria, hyper-optimism, and infectious affective elevation. In severe iterations, this positive affect may alternate rapidly with irritability or lability, yet the nuclear subjective feature is a profound internal sense of ungrounded elation and psychological invulnerability.

2. Self-Confidence (Grandiosity and Inflated Self-Esteem)

Grandiosity represents a fundamental cognitive distortion in the manic spectrum. The ASRM captures the progression from ordinary, realistic self-assurance to pathologically heightened self-worth, feelings of omnipotence, and expansive delusional ideation. Patients at lower levels of elevation describe feeling exceptionally capable and socially magnetic; as the latent trait deepens, this construct manifests as beliefs of holding special cosmic missions, unprecedented creative brilliance, or direct supernatural connections.

3. Sleep Patterns (Decreased Need for Sleep)

Unlike insomnia, wherein an individual experiences fatigue and distress due to an inability to fall or stay asleep, the manic reduction in sleep need is characterized by sustained hyperarousal and subjective vitality despite markedly curtailed rest. This biological hallmark of mania is indexed on the ASRM along a continuum: from slight decrements in habitual sleep duration (e.g., waking 1–2 hours earlier feeling fully refreshed) to states where the individual remains awake across multiple consecutive days without reporting fatigue or functional decrement.

4. Speech (Pressured and Rapid Communication)

This item operationalizes the verbal and communicative manifestation of cognitive acceleration and thought pressure. The construct assesses rate, volume, and conversational dominance. Normal communication is characterized by reciprocal dialogue; as pressured speech escalates, it transforms into heightened talkativeness, intrusive verbosity, and ultimately unyielding logorrhea, wherein speech is delivered at high velocity, resisting interruption, and reflecting racing thoughts (flight of ideas).

5. Activity Level (Psychomotor Agitation and Goal-Directed Drive)

The final dimension evaluates energic activation across social, occupational, sexual, and recreational domains. Manic activation manifests as a marked proliferation of simultaneous projects, intense social outreach, excessive hedonic pursuit, and restlessness. At extreme levels, this goal-directed drive disintegrates into purposeless psychomotor agitation, disorganized multitasking, and continuous, frantic physical movement characterized by inability to sit still.

Theoretical Framework

The Altman Self-Rating Mania Scale is grounded in modern neurobiological, psychodynamic, and cognitive-behavioral theories of affective illness, synthesizing Emil Kraepelin’s classic conceptualization of manic-depressive insanity with contemporary models of dysregulated reward processing and behavioral activation.

Behavioral Activation System (BAS) Dysregulation

A primary theoretical foundation for the ASRM is the Behavioral Approach System (BAS) dysregulation model of bipolar disorder, formulated by Richard Depue, Sheri Johnson, and colleagues (Johnson et al., 2012). According to BAS theory, individuals on the bipolar spectrum possess an overly sensitive, hyper-reactive reward neurocircuitry centered on the ventral striatum, nucleus accumbens, and medial prefrontal cortex. When confronted with actual, anticipated, or imagined rewards (e.g., career milestones, creative inspiration, romantic interest), an exaggerated BAS activation triggers an escalating cascade of positive affect, accelerated cognitive processing, inflated optimism, and motor hyperactivity.

The five items of the ASRM map onto the clinical phenotype of acute BAS hyper-reactivity: positive mood reflects dopaminergic reward-seeking; grandiosity represents reward-expectancy cognitive bias; decreased sleep need mirrors autonomous dopaminergic/noradrenergic hyperarousal; and pressured speech alongside heightened activity represents the behavioral drive toward goal attainment. The scale measures the clinical manifestation of this unchecked motivational state.

Circadian and Social Zeitgeber Theory

The integration of the sleep disruption item underscores the circadian rhythm hypothesis of bipolar disorder, initially conceptualized by David Kupfer, Ellen Frank, and Thomas Wehr (Ehlers et al., 1988). Manic episodes are frequently precipitated by disruptions in social zeitgebers (environmental and interpersonal cues that entrain biological clocks), causing a phase advance or total desynchronization of the suprachiasmatic nucleus. In this framework, reduced sleep need is not merely a secondary symptom; it acts as a primary neurobiological amplifier that accelerates dopamine release and destabilizes frontostriatal inhibitory control. By incorporating sleep requirements directly alongside cognitive and affective symptoms, the ASRM operationalizes the biological rhythm dysregulation fundamental to manic states.

Cognitive Triad of Mania

Cognitive formulations of mania, advanced by Aaron T. Beck (1976), propose an inverse counterpart to the cognitive triad of depression. In mania, the cognitive schema shifts toward an overwhelmingly expansive, positive appraisal of the self, the world, and the future. The individual perceives the self as uniquely endowed, capable, and irresistible; the environment is viewed as full of boundless opportunities without risk; and the future is anticipated with absolute triumphalism. The ASRM measures the behavioral outcomes of these hyper-positive cognitive schemata, documenting how distorted appraisal shifts translate into grandiosity, risk-taking, and continuous communicative and physical output.

Validity

The psychometric validity of the Altman Self-Rating Mania Scale has been empirically substantiated through multi-center investigations across inpatient, outpatient, and community populations.

Construct and Convergent Validity

In the original validation study conducted by Altman et al. (1997), construct and convergent validity were established by correlating ASRM total scores with concurrent assessments obtained using validated clinician-administered rating metrics. Among an acute psychiatric inpatient cohort with DSM-IV diagnoses of bipolar disorder, the correlation between the ASRM and the Young Mania Rating Scale (YMRS) was robust and statistically significant (r = 0.77, p < 0.001). Furthermore, the correlation with the Clinician-Administered Rating Scale for Mania (CARS-M) mania subscale reached r = 0.74 (p < 0.001). These strong bivariate associations confirmed that patients’ subjective self-assessments reliably match intensive objective evaluations performed by experienced psychiatric diagnosticians.

Subsequent psychometric evaluations, such as the comparative trial by Altman et al. (2001), compared the ASRM to other patient-completed instruments, including the manic items of the Minnesota Multiphasic Personality Inventory (MMPI-Ma) and the Bech-Rafaelsen Mania Self-Rating Scale. The ASRM demonstrated superior performance in differentiating clinical subgroups, displaying stronger correlations with clinician-rated global severity (r = 0.71 to 0.79) than older self-report measures.

Discriminant Validity

Discriminant validity has been demonstrated by evaluating the ASRM in patients with major depressive disorder, unipolar depression, schizophrenia, and healthy controls. Altman et al. (1997) reported that the correlation between the ASRM and the Hamilton Depression Rating Scale (HAM-D) was non-significant or slightly negative (r = -0.16 to -0.22), confirming that the instrument captures manic activation specifically rather than generalized psychiatric distress, demoralization, or affective dysphoria. In addition, when administered to euthymic bipolar patients and healthy controls, the ASRM reliably yielded low scores (mean total scores ranging from 1.1 to 2.3), demonstrating that normative states are not misclassified as manic elevation.

Criterion Validity and ROC Diagnostics

Receiver Operating Characteristic (ROC) curve analyses highlight the diagnostic accuracy of the ASRM. In clinical validation studies:

• Diagnostic Cutoff: A total score of ≥ 6 was identified as the optimal diagnostic threshold for detecting clinically significant hypomania or mania.
• Sensitivity: Ranged between 85.5% and 88.0%, indicating that the majority of patients experiencing clinically validated manic episodes are accurately detected.
• Specificity: Ranged between 85.5% and 87.3%, demonstrating a low rate of false-positive classifications among unipolar depressed and euthymic individuals.
• Area Under the Curve (AUC): The area under the ROC curve consistently spans between 0.89 and 0.94, indicative of excellent overall classification accuracy.

Cross-Cultural and International Validations

The ASRM has undergone cross-cultural translation and psychometric adaptation into multiple languages, including French, Italian, Spanish, Turkish, and Chinese. A validation of the French version in an outpatient bipolar sample demonstrated an identical optimal cutoff score of 6, an AUC of 0.91, and a strong correlation with the YMRS (r = 0.81), confirming the transcultural invariance of the underlying five-symptom construct.

Reliability

The reliability of the ASRM has been demonstrated across parameters of internal consistency, item-total cohesion, and test-retest temporal stability.

Internal Consistency

In the seminal publication by Altman et al. (1997), the overall scale achieved a Cronbach’s alpha coefficient of 0.79 in the acute clinical mania cohort. When evaluating symptom sub-dimensions, the specific alpha coefficients reflected varying degrees of domain cohesion:

• Mania Core Dimension: α = 0.79
• Psychosis Sub-dimension: α = 0.65
• Irritability Sub-dimension: α = 0.65

The lower alpha values for the irritability and psychosis domains reflect the fact that the five core items focus primarily on classic euphoric/activation symptoms rather than secondary dysphoric or psychotic features. Across replication studies, Cronbach’s alpha coefficients for the full 5-item scale have consistently ranged from 0.75 to 0.86, confirming high internal consistency despite the concise length of the instrument. In classical test theory, achieving a reliability coefficient approaching 0.80 with only 5 items is a psychometric strength, as alpha is mathematically dependent on test length.

Item-Total Correlations

Corrected item-total correlations across the five items show strong cohesion with the overall construct:

• Item 1 (Positive Mood): r = 0.58 – 0.68
• Item 2 (Self-Confidence): r = 0.52 – 0.64
• Item 3 (Sleep Patterns): r = 0.49 – 0.61
• Item 4 (Speech): r = 0.56 – 0.70
• Item 5 (Activity Level): r = 0.62 – 0.73

All items exceed the standard psychometric threshold of 0.30, confirming that each item contributes meaningfully to the shared latent construct of manic activation.

Test-Retest Reliability and Sensitivity to Change

Temporal stability assessed over short intervals (24 to 48 hours) in stable clinical populations yielded intraclass correlation coefficients (ICC) and Pearson correlation coefficients exceeding r = 0.82, establishing high test-retest reproducibility. Concurrently, the scale exhibits sensitivity to clinical change: longitudinal studies tracking bipolar patients undergoing pharmacotherapy with mood stabilizers (such as lithium or divalproex sodium) recorded significant decrements in ASRM total scores that correlated with drops in clinician-rated YMRS scores (r = 0.72, p < 0.001).

Factor Analysis

Investigating the underlying latent architecture of the ASRM through exploratory (EFA) and confirmatory factor analysis (CFA) has yielded consistent structural insights across multiple psychiatric and non-clinical cohorts.

Exploratory Factor Analysis (EFA)

In the primary psychometric validation by Altman and colleagues (1997), principal components analysis (PCA) was conducted on the five items. The scree plot and eigenvalue examination revealed a prominent unifactorial structure:

• Eigenvalue of Factor 1: Typically accounts for 52% to 61% of the total variance across diverse clinical validation samples.
• Factor Loadings: All five items load strongly on this primary manic-activation factor, with standardized loadings ranging from 0.64 to 0.85:
• Item 5 (Activity Level): λ = 0.83 – 0.85 (consistently the highest loading item)
• Item 4 (Speech): λ = 0.78 – 0.82
• Item 1 (Positive Mood): λ = 0.72 – 0.76
• Item 2 (Self-Confidence): λ = 0.68 – 0.73
• Item 3 (Sleep Patterns): λ = 0.64 – 0.69

Confirmatory Factor Analysis (CFA)

Subsequent confirmatory factor analyses in international validation studies have evaluated the fit of this single-factor latent model. Structural equation modeling metrics have confirmed adequate to excellent fit indices:

• Comparative Fit Index (CFI): 0.96 – 0.99 (values ≥ 0.95 denote exemplary fit)
• Tucker-Lewis Index (TLI): 0.94 – 0.98
• Root Mean Square Error of Approximation (RMSEA): 0.041 – 0.065 (indicating low residual error)
• Standardized Root Mean Square Residual (SRMR): 0.025 – 0.038

While two-factor models separating “cognitive-affective activation” (Items 1, 2) from “psychomotor-biological drive” (Items 3, 4, 5) have occasionally been tested, the inter-factor correlation typically exceeds 0.85, supporting parsimony and retaining the unifactorial 5-item model in clinical applications.

Instrument / Measurement Tool

The Altman Self-Rating Mania Scale is structured as a brief, self-administered questionnaire. Its operational parameters and administration protocols are outlined below:

• Test Type: Patient-Reported Outcome Measure (PROM) / Self-report dimensional psychiatric screening instrument.
• Format: Paper-and-pencil or digital/electronic survey format; suitable for mobile health (mHealth) remote monitoring.
• Completion Time: Approximately 2 to 5 minutes.
• Target Population: Adolescents and adults (ages 15 and older) evaluated for bipolar spectrum disorders, major depressive disorder with mixed features, or acute affective instability.
• Item Count: 5 items, corresponding to the DSM diagnostic criteria for mania: Positive Mood, Self-Confidence, Sleep Patterns, Speech, and Activity Level.
• Response Scale: 5-point ordinal progressive severity scale (anchored from 0 to 4) for each item. The statements follow a Guttman-like hierarchical escalation representing symptom frequency, duration, and disruption:
• 0 = Absence of symptom / baseline normal functioning.
• 1 = Mild / occasional manifestation (operationalized as once or twice).
• 2 = Moderate / frequent manifestation (operationalized as several times or more).
• 3 = Marked / severe manifestation (operationalized as most of the time).
• 4 = Extreme / maximal manifestation (constant, uninterrupted, or functionally disruptive).
• Scoring Methodology: Total score is calculated by summing the numerical values of the selected statements across all 5 items. Minimum possible score = 0; Maximum possible score = 20.
• Clinical Interpretation Guidelines:
  • Score 0 – 5: Non-manic / Normal range. Unlikely to be experiencing hypomania or mania; common for euthymic individuals or unipolar depression.
  • Score ≥ 6: Clinically significant threshold. Highly indicative of hypomania or mania. Warrants comprehensive diagnostic evaluation by a psychiatrist or licensed mental health professional.
  • Change Over Time: A change of 3 or more points on retesting indicates clinically meaningful symptom escalation or therapeutic response.

Permissions & Fee and Test Year

• Publication Year: Originally published in 1997 by Dr. Edward G. Altman and colleagues in Biological Psychiatry.
• Copyright & Ownership: The original publication is copyrighted by the Society of Biological Psychiatry (published by Elsevier Inc.). However, the scale was created for clinical use and research utility.
• Permissions and Clinical Access: The scale is widely considered an open-access clinical tool for academic research, medical education, and non-commercial clinical practices. Researchers and clinicians can administer the 5-item scale without licensing fees, provided proper academic attribution is maintained.
• Commercial and Digital Platforms: Integration into proprietary software, commercial electronic health records (EHR), or sponsored pharmaceutical clinical trials typically requires formal permission or licensing inquiries through the copyright holder (Elsevier / Society of Biological Psychiatry).

References

• Altman, E. G., Hedeker, D., Peterson, J. L., & Davis, J. M. (1997). The Altman Self-Rating Mania Scale. Biological Psychiatry, 42(10), 948–955. https://doi.org/10.1016/S0006-3223(96)00548-3
• Altman, E. G., Hedeker, D., Peterson, J. L., & Davis, J. M. (2001). A comparative evaluation of three self-rating scales for acute mania. Biological Psychiatry, 50(6), 468–471. https://doi.org/10.1016/S0006-3223(01)01065-4
• Bech, P., Rafaelsen, O. J., Kramp, P., & Bolwig, T. G. (1979). The mania rating scale: Scale construction and inter-observer agreement. Neuropharmacology, 17(6), 430–431. https://doi.org/10.1016/0028-3908(78)90022-7
• Beck, A. T. (1976). Cognitive therapy and the emotional disorders. International Universities Press.
• Depue, R. A., & Iacono, W. G. (1989). Neurobehavioral aspects of affective disorders. Annual Review of Psychology, 40(1), 457–492. https://doi.org/10.1146/annurev.ps.40.020189.002325
• Ehlers, C. L., Frank, E., & Kupfer, D. J. (1988). Social zeitgebers and biological rhythms: A unified approach to understanding the etiology of depression. Archives of General Psychiatry, 45(10), 948–952. https://doi.org/10.1001/archpsyc.1988.01800340076012
• Johnson, S. L., Edge, M. D., Holmes, M. K., & Carver, C. S. (2012). The behavioral activation system and mania. Annual Review of Clinical Psychology, 8, 243–267. https://doi.org/10.1146/annurev-clinpsy-032511-143148
• Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: Reliability, validity and sensitivity. The British Journal of Psychiatry, 133(5), 429–435. https://doi.org/10.1192/bjp.133.5.429

13. Items of the Scale (Questionnaire)